Brazilian researchers have identified previously unknown forms of a protein linked to breast cancer. The discovery ...

Bristol Myers Squibb (NYSE:BMY) said on Tuesday that it has entered into a partnership with Microsoft (NASDAQ:MSFT) to ...

Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology ...

Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

By Elizabeth Chapin University of Kentucky The University of Kentucky Markey Cancer Center has treated the first patient in ...

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...

Ibuprofen’s anti-inflammatory action may influence cancer risk, but evidence remains complex and routine use for prevention is not advised. Ibuprofen is one of the most widely used pain relievers, ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune system better recognize and respond to small cell lung cancer. The study aims to ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.